European Journal of Pharmacology

Print ISSN
0014-2999
Electronic ISSN
1879-0712
Impact factor
2.737
Publisher
Sciencedirect
URL
http://www.sciencedirect.com/science/journal/00142999
Usage rank
324
Article count
29955
Free count
75
Free percentage
0.00250376
PDFs via platforms
Ingenta, Sciencedirect, Gale, Proquest, CSA, and Rcgp

  1. Editorial Board
    Author(s) unavailable

    European Journal of Pharmacology 766:ii (2015)

  2. Editorial Board
    Author(s) unavailable

    European Journal of Pharmacology 765:ii (2015)

  3. Editorial Board
    Author(s) unavailable

    European Journal of Pharmacology 764:ii (2015)

  4. Editorial Board
    Author(s) unavailable

    European Journal of Pharmacology 763:ii (2015)

  5. Editorial Board
    Author(s) unavailable

    European Journal of Pharmacology 759:ii (2015)

  6. Editorial Board
    Author(s) unavailable

    European Journal of Pharmacology 758:ii (2015)

  7. Editorial Board
    Author(s) unavailable

    European Journal of Pharmacology 756:ii (2015)

  8. Editorial Board
    Author(s) unavailable

    European Journal of Pharmacology 755:ii (2015)

  9. Editorial Board
    Author(s) unavailable

    European Journal of Pharmacology 754:ii (2015)

  10. Editorial Board
    Author(s) unavailable

    European Journal of Pharmacology 753:ii (2015)

  11. Editorial Board
    Author(s) unavailable

    European Journal of Pharmacology 752:ii (2015)

  12. Editorial Board
    Author(s) unavailable

    European Journal of Pharmacology 751:ii (2015)

  13. Editorial Board
    Author(s) unavailable

    European Journal of Pharmacology 750:ii (2015)

  14. Editorial Board
    Author(s) unavailable

    European Journal of Pharmacology 749:ii (2015)

  15. Editorial Board
    Author(s) unavailable

    European Journal of Pharmacology 748:ii (2015)

  16. Editorial Board
    Author(s) unavailable

    European Journal of Pharmacology 747:ii (2015)

  17. Announcement EPHAR
    Author(s) unavailable

    European Journal of Pharmacology 746:I (2015)

  18. Editorial Board
    Author(s) unavailable

    European Journal of Pharmacology 746:ii (2015)

  19. Pro-resolving mediators produced from EPA and DHA: Overview of the pathways involved and their mechanisms in metabolic syndrome and related liver diseases

    European Journal of Pharmacology (2015)

    A novel genus of pro-resolving lipid mediators endogenously generated from omega-3 polyunsaturated fatty acids has been identified in exudates obtained during the resolution phase of acute inflammation. The term specialized pro-resolving mediators (SPM) has been coined for these lipid ...
  20. Polydatin improves glucose and lipid metabolism in experimental diabetes through activating the Akt signaling pathway

    European Journal of Pharmacology 745:152 (2014)

    Recently, the effect of polydatin on lipid regulation has gained considerable attention. And previous study has demonstrated that polydatin has hypoglycemic effect on experimental diabetic rats. Repressed Akt pathway contributes to glucose and lipid disorders in diabetes. Thus, whether...